Back to Search Start Over

Bob More.

Source :
Nature Reviews Drug Discovery; Sep2014, Vol. 13 Issue 9, p648-648, 1p
Publication Year :
2014

Abstract

A interview with Bob More, head of venture investing for the Bill & Melinda Gates Foundation, is presented. When asked on why the Foundation needs to make venture capital investments, he refers to the goals of trustees and leadership at the Foundation requiring them to work with smartest people to achieve them. He says that they have a philosophy with their partners that they cal broadly global access. More says that he believed that the biotechnology industry was going to change the world.

Details

Language :
English
ISSN :
14741776
Volume :
13
Issue :
9
Database :
Complementary Index
Journal :
Nature Reviews Drug Discovery
Publication Type :
Academic Journal
Accession number :
97803855
Full Text :
https://doi.org/10.1038/nrd4421